No longer just for telling us more about the mutations in our genes, next-generation sequencing has advanced into the clinic where it is poised to directly impact patient’s lives. Among the patient-focused NGS initiatives making an impact are the 100,000 Genomes Project (focused on providing diagnostic tools for patients with rare diseases), the Actionable Genome Consortium (working toward a clearer definition of an “actionable cancer genome”), and BabySeq (which aims to investigate the impact of WGS on the well-being of babies and their parents). Learn more about these initiatives and their considerable goals here.
Learn More